(Q52671559)

5 May 2018

title

Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen. (English)

1 reference

5 May 2018

author name string

Pavlo Sakhatskyy

1

1 reference

5 May 2018

Shixia Wang

2

1 reference

5 May 2018

Te-Hui W Chou

3

1 reference

5 May 2018

Shan Lu

4

1 reference

5 May 2018

language of work or name

English

0 references

publication date

21 August 2006

1 reference

5 May 2018

published in

Virology

1 reference

5 May 2018

volume

355

1 reference

5 May 2018

issue

2

1 reference

5 May 2018

page(s)

164-174

1 reference

5 May 2018

An antigenic difference between intracellular and extracellular rabbitpox virus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Neutralizing and protective antibodies directed against vaccinia virus envelope antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

The looming threat of bioterrorism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Application of the polyvalent approach to HIV-1 vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Neutralizing epitope on penetration protein of vaccinia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Antibody neutralization of the extracellular enveloped form of vaccinia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Inducible gene expression from vaccinia virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

The A17L gene product of vaccinia virus is exposed on the surface of IMV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Clonal vaccinia virus grown in cell culture as a new smallpox vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.017

7 January 2021

inferred from DOI database lookup

[Insertion mutants of the vaccinia virus. The effect of inactivating E7R and D8L genes on the biological properties of the virus]

1 reference

12 December 2020

Amino acid sequence determination of vaccinia virus immunodominant protein p35 and identification of the gene

1 reference

12 December 2020

Delivery of DNA to skin by particle bombardment

1 reference

12 December 2020

Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25

1 reference

12 December 2020

Structural and functional characterization of a cell surface binding protein of vaccinia virus.

1 reference

12 December 2020

Differences between extracellular and intracellular forms of poxvirus and their implications

1 reference

12 December 2020

Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans

1 reference

12 December 2020

Human cytotoxic T-cell memory: long-lived responses to vaccinia virus

1 reference

12 December 2020

10.1016/J.VIROL.2006.07.017

Identifiers

DOI

1 reference

5 May 2018

PMC publication ID

7126721

0 references

1 reference

5 May 2018